Position in GTBP
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$38,199
New position
Shares Held
93,627
first reported quarter
Ownership
0.260%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $6,222,201 across 181 Biotechnology names. GTBP ranks #21 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
18,720 | $802,900 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,423 | $635,426 | |
| 3 | TECH |
BIO-TECHNE Corp
|
11,543 | $603,237 | |
| 4 | INCY |
Incyte Corp
|
6,007 | $565,378 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
613 | $473,628 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
2,012 | $380,368 | |
| 7 | MESO |
Mesoblast Ltd
|
24,425 | $375,656 | |
| 8 | CGEN |
Compugen Ltd
|
131,800 | $280,734 |
All Filings in GTBP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,199 | 93,627 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||